1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by β-naphthoflavone-pretreatment
- 1 June 1991
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 127 (2) , 247-250
- https://doi.org/10.1016/0304-3940(91)90804-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Irreversible inhibition of monoamine oxidase by some components of cigarette smokeLife Sciences, 1987
- Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controlsInternational Journal of Cancer, 1987
- VI. Studies on the mechanism of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine cytotoxicity in isolated hepatocytesLife Sciences, 1987
- V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP+ concentrations and neurotoxicityLife Sciences, 1987
- MPTP: Insights into the Etiology of Parkinson’s DiseaseEuropean Neurology, 1987
- Chronic nicotine administration incrreases binding of [3H]Domperidone in rat nucleus accumbensJournal of Neuroscience Research, 1987
- Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractionsJournal of Medicinal Chemistry, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Smoking and Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- Low platelet monoamine oxidase activity in cigarette smokersLife Sciences, 1981